Trial Profile
Safety, tolerability and sedative properties of single dose intranasal dexmedetomidine premedication in elderly subjects.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2016
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Anxiety disorders; Sedation
- Focus Adverse reactions
- Acronyms KUKIDEX-1
- 10 Mar 2016 New trial record